Celesio UK, which owns brands Betterlife Healthcare, LloydsPharmacy and John Bell & Croyden, all of which deal in mobility aids, has rebranded after what has been a challenging 12 months.
The company is now called McKesson UK, in line with American parent group, McKesson, which acquired the majority of publicly owned shares in Celesio in 2014.
McKesson UK will replace Celesio on corporate communications that cover the UK business but its customer-facing brands, including Betterlife, will not change.
Toby Anderson (pictured) joined as McKesson UK’s new CEO in May after the former boss, Cormac Tobin, departed the company just over a year ago following the mass closure and selling of around 190 LloydsPharmacy stores.
Mr Anderson said that in the UK the group has to be prepared to “meet the evolving needs of patients and care delivery” and that it seemed an “appropriate time” to move to its new brand.
“The McKesson name is one that resonates particularly with pharmaceutical manufacturers and other strategic partners that we work with,” he said.
“However, the millions of patients and customers we see every day in LloydsPharmacy won’t notice any difference and our AAH vans will still deliver to every dispensing point in the country.
“Having a strong, internationally-recognised brand will help us grow our business and continue to make our colleagues proud of where they work.”
McKesson UK brands have made a number of changes in how they operate in recent months.
Betterlife, the group’s flagship mobility equipment retailer, has closed two stores this year but it has insisted this is part of its “evolution”.
A spokesperson said that the company’s stance for any new customer proposition is to “continuously take on customer feedback about what they like and what they think we could change”.
The firm said that the stores closures came as it found “new ways to evolve in order to achieve excellence in quality, range of products and convenience.”
Meanwhile, McKesson’s flagship Harley Street pharmacy, John Bell & Croyden, has grown significantly following huge investment in its Central London site.
McKesson UK provides various healthcare services to the NHS specialising in medicines, pharmaceutical care and primary care patient services. It has 22,500 employees and more than 1,600 LloydsPharmacy community pharmacies.
With 118 wholesale branches in Europe, McKesson Europe supplies more than 50,000 pharmacies and hospitals every day with more than 100,000 pharmaceutical products.